563 Skin-infiltrating Th17/Tc17 and Th1/Tc1cells are significantly decreased and IL-17+ CD103+ resident memory T cells partly remain after secukinumab treatment

Authors :: Toshiharu Fujiyama
Kazuo Kurihara
Hiroaki Yagi
Yoshiki Tokura
Takatsune Umayahara
Hideo Hashizume
T. Itou
Takatoshi Shimauchi
Source :: Journal of Investigative Dermatology. 138:S96
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: business.industry
Immunology
Medicine
Secukinumab
Cell Biology
Dermatology
Interleukin 17
business
Molecular Biology
Biochemistry

Full Text Access

Tools